RE:RE:with TLT at 2.5% the value of phase 1 LSD play MMED...Concerning that the regulars here don't have questions around the valuation drought...
You know "fellas"...when "money" is required, it tends to get done based on current valuations..
Lest we forget the 55 cent bullboard hype and subsequent 30 cent financing with a 35 cent sidecar....followed of course by 12.7M options at 25 pennies CAD.
INBOX me for further private convo.
Hmmmmmmmm ; - ) !!!
WHAT possible benefit could there be to this unusual "lack of value"?
Is it wise to slap a 100M prospectus for the "market" to consider?
I don't understand the "logic"??
We have a FDA FASTTRACK and a valuation of 50M CAD vs. the LSD company at 2BILLION CAD
What is wrong and what are we doing to rectify the poor market cap?
In fareness...they do have ecstacy and now mescaline studies too as far as I know....but does that really allow us to be worth 2.5% their value?